Showing results (21-30 of 1,128) with videos related to
Sort By:
Pageof 113
Nordisk Medicin|January 1, 1990
[The effect of diet on the treatment of malignant diseases]R Henriksson, P Bergström, K GrankvistPharmacology & Toxicology|July 1, 1989
Comparative study of demethoxydaunorubicin with other anthracyclines on generation of oxygen radicals and clonogenic survival of fibroblastsK Grankvist, U Stendahl, R HenrikssonEuropean Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinomaB Ljungberg, K Grankvist, T RasmusonInternational Journal of Cancer|July 31, 2001
Cisplatin-induced apoptosis of mesothelioma cells is affected by potassium ion flux modulator amphotericin B and bumetanideL Marklund, R Henriksson, K GrankvistEuropean Urology|January 1, 1992
Erythropoietin in renal cell carcinoma: evaluation of its usefulness as a tumor markerB Ljungberg, T Rasmuson, K GrankvistActa Oncologica (Stockholm, Sweden)|January 1, 1996
Serum beta 2-microglobulin and prognosis of patients with renal cell carcinomaT Rasmuson, K Grankvist, B LjungbergInternational Journal of Cancer|April 22, 1997
Evaluation of five glycoprotein tumour markers (CEA, CA-50, CA-19-9, CA-125, CA-15-3) for the prognosis of renal-cell carcinomaK Grankvist, B Ljungberg, T RasmusonActa Pharmacologica Et Toxicologica|March 1, 1986
Rubidium uptake by mouse pancreatic islets exposed to 6-hydroxydopamine, ninhydrin, or other generators of hydroxyl radicalsK Grankvist, J Sehlin, I B TäljedalCancer Letters|June 15, 1992
Amiloride but not bumetanide protects against the cytotoxic effects of estramustine and bleomycin in cultured fibroblastsK Grankvist, R Henriksson, P E SandströmDrug Metabolism and Drug Interactions|January 1, 1992
Chlorpromazine enhancement of epirubicin cytotoxicity in vitro: effects on plasma membrane and DNA damageP B Mothlagh, R Henriksson, K GrankvistPageof 113